Wang, G., Zhang, C., Tang, J., Ma, Y., Li, Q., Su, D., Lou, C., Ma, Z., Song, H., Zhang, Y. (2026). Cadonilimab in combination with ivonescimab and chemotherapy as first-line (1L) therapy in patients with advanced gastric (G) or gastroesophageal junction adenocarcinoma (GEJA): Updated results from an open-label phase II trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.4048